Metformin Hydrochloride Zentiva Pharma

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Zentiva Pharma, is a biguanide presented as an oral dosage form for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus.

GNH USA supplies Metformin Hydrochloride Zentiva Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is indicated for the management of type 2 diabetes mellitus, a chronic metabolic disorder characterized by insulin resistance and elevated blood glucose.

- Type 2 diabetes mellitus: Improves glycemic control by reducing hepatic glucose production and enhancing peripheral insulin sensitivity.

Metformin Hydrochloride may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea: frequent loose stools, especially during treatment initiation. - Metallic taste: transient alteration in taste perception. - Vitamin B12 deficiency: reduced absorption with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening accumulation of lactate. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: abnormal liver enzymes indicating liver injury. - Hypoglycemia: when combined with other glucose‑lowering agents. - Pancreatitis: inflammation of the pancreas presenting with abdominal pain.

Metformin Hydrochloride requires careful patient assessment and monitoring to minimize risks.

- Renal function assessment: evaluate eGFR before initiating and periodically thereafter. - Lactic acidosis risk: avoid in patients with severe renal impairment, hepatic disease, or conditions predisposing to hypoxia. - Alcohol consumption: limit intake as excessive alcohol increases lactic acidosis risk. - Pregnancy and lactation: use only if potential benefits outweigh risks. - Drug interactions: review concomitant medications for possible interactions. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Metformin Hydrochloride can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations, enhancing toxicity. - Nitrates: combined use may cause severe hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Thiazide diuretics: can attenuate metformin’s glucose‑lowering effect. - ACE inhibitors or ARBs: monitor renal function and electrolytes during co‑administration.